Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research (Paperback)

~ Robert Bonk (Author) "Information explodes around us through our modern technology, and perhaps nowhere more than in health care..." (more)
Key Phrases: external medical community, pharmaceutical documents, nonclinical research, New Drug Application, United States, Basic Introduction (more...)

Editorial Reviews

Product Description

Guide covering regulatory writing, audience analysis, and ethical responsibilities of biomedical writers. For students and practitioners. Softcover. DNLM: Writing.

Product Details

• Paperback: 139 pages
• Publisher: Routledge; 1 edition (January 15, 1998)
• Language: English
• ISBN-10: 0789004496
• ISBN-13: 978-0789004499
• Product Dimensions: 8.3 x 5.9 x 0.6 inches
• Shipping Weight: 8.8 ounces (View shipping rates and policies)
• Average Customer Review: 3.0 out of 5 stars  See all reviews (3 customer reviews)
• Amazon.com Sales Rank: #1,144,507 in Books (See Bestsellers in Books)

Customer Reviews

Most Helpful Customer Reviews

39 of 40 people found the following review helpful:

2.0 out of 5 stars Not a practical guide, more a manifesto !, April 17, 1998

By	[e-mail] (Chapel Hill, NC and San Diego, CA) - See all my reviews

This review is from: Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research (Hardcover)

Dr. Bonk is a seasoned professional who has worked at all levels of his craft, including the highest. This book is entitled "a practical guide for pharmaceutical research", and specifically concentrates on the output of documents from the pharmaceutical industry (regulatory documents and manuscripts, as well as, to a lesser extent, audio-visual preparations and computer-generated products). I bought the book because it was the only one that specifically addresses the needs of those of us working in the pharmaceutical industry.

This book is a manifesto, or one (alternative) philosophy, for the role of the medical writer in a pharmaceutical company. As such, its greatest achievement will be to attract people with talent into an occupation that is sorely in need of more and better writers. If this book stimulates under-graduates or graduates to explore this profession, then it will have made a significant, contribution to pharmaceutical research.

However, this book falls far short of being a practical guide. It is not, nor does it claim to be, a style guide; this is not a deficiency in itself. But to be a practical guide, there is much more that it needs to consider: how do medical writers multi-task, and manage their inevitably numerous assignments all at varying degrees of completion ? What should one look for in word processing software, and is this the same for everybody ? How can one enhance one's interactions with journal editors ? What are the relevant professional guilds and associations, and what are their courses and credentials like ? These are a few of the practical things, outside questions of style, that medical writers need to work inside the pharmaceutical industry.

The document templates provided (and lauded in the book's advertising) are poor. The regulatory documents should have followed closely the ICH or FDA guidelines (neither is new). A reprinted, stellar example of a published paper, with some illuminating commentary, and even some succes!sive stages of drafting, would have been an asset.

The initial sections of this book attempt to teach about the drug development process. Unless this can be done more thoroughly (and preferably by someone who has actually developed drugs), this description is inadequate to equip a medical writer in a pharmaceutical company. The descriptions are out of date and garbled in places. There are medical writers who indeed significantly contribute to drug development in the way that Dr. Bonk envisages, but they know a lot more than this about how new drugs are discovered and approved.

Lesser criticisms include the production of this book. At a little over 100 loosely worded pages it is not inexpensive. But its printing is cheap, and the figures were especially poorly printed in my copy. The figures, too, were often redundant; for example, the "pyramids" of the components of a medical journal manuscript were especially irrelevant.

In summary, this book is unique in giving a sound philosophy for the medical writer in a pharmaceutical company. As a practical guide (its stated claim) it is a real failure. This reviewer now understands why its plaudits were written by Professors of English in liberal arts schools, and not by experienced pharmaceutical industry personnel.

A.W.Fox, MD, PhD, FFPM

5 of 6 people found the following review helpful:

4.0 out of 5 stars Useful for a newcomer to the clinical trial environment, May 3, 2001

By	J. Levinson (Media, PA USA) - See all my reviews (REAL NAME)

As a clinical trials computer programmer, I'm not the primary target audience for this book. However, as an experienced programming consultant who was new to clinical studies in the pharmaceutical industry, I found it gave me a useful overview of the typical deliverables that my efforts supported. Acronyms that are frequently used in the clinical environment, such as IB (Investigator's Brochure) and ISS (Integrated Safety Study) are given some definition and examples are shown. I found this information valuable in enabling me to feel comfortable with these concepts when they were discussed in meetings with statisticians and project managers.

3.0 out of 5 stars Basic but Useful, March 4, 2009

By	Stefan Schuber "sschuber" (Gaithersburg, MD - ex Eugene, OR) - See all my reviews (REAL NAME)

This book is a bit dated, especially if one follows FDA guidance documents, but it offers several advantages, including clear writing and logical organization. It might benefit from an update that includes current thinking by the International Conference on Harmonization, but these documents are readily available on-line. For relative novices this will be a good resource, but more experienced medical writers may find it a tad basic.